News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

InspireMD (NYSE:NSPR) was given a new $5.00 price target on by analysts at Loop Capital.

InspireMD (NYSE:NSPR) had its "buy" rating reaffirmed by analysts at Lake Street Capital.

InspireMD (NYSE:NSPR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $6.00 price target on the stock.

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)

11/4/2025

07:00 am

NSPR

-8.0%

IN-LINE

8/5/2025

08:00 am

NSPR

-15.2%

MISS

5/9/2025

07:00 am

NSPR

3.9%

MISS

3/12/2025

07:00 am

NSPR

-2.8%

BEAT

Form 8-K InspireMD, Inc. For: Feb 27

Form 4/A InspireMD, Inc. For: Dec 09 Filed by: Stuka Paul

Form SCHEDULE 13G InspireMD, Inc. Filed by: ORBIMED ADVISORS LLC

Form SCHEDULE 13G/A InspireMD, Inc. Filed by: Rosalind Advisors, Inc.

Form 4 InspireMD, Inc. For: Jan 15 Filed by: Gleason Shane Thomas

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}